175 related articles for article (PubMed ID: 11487199)
1. Presymptomatic tests in Huntington's disease and dominant ataxias.
Cannella M; Simonelli M; D'Alessio C; Pierelli F; Ruggieri S; Squitieri F
Neurol Sci; 2001 Feb; 22(1):55-6. PubMed ID: 11487199
[TBL] [Abstract][Full Text] [Related]
2. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
3. Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians.
Mariotti C; Ferruta A; Gellera C; Nespolo C; Fancellu R; Genitrini S; Di Bella D; Panzeri M; Nanetti L; Tomasello C; Taroni F; Foresti G; Astori S
Eur Neurol; 2010; 64(1):33-41. PubMed ID: 20588047
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype.
Rodrigues GR; Walker RH; Bader B; Danek A; Brice A; Cazeneuve C; Russaouen O; Lopes-Cendes I; Marques W; Tumas V
Arq Neuropsiquiatr; 2011 Jun; 69(3):419-23. PubMed ID: 21755114
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
[TBL] [Abstract][Full Text] [Related]
6. Huntington Disease: Genetics, Prevention, and Therapy Approaches.
Yapijakis C
Adv Exp Med Biol; 2017; 987():55-65. PubMed ID: 28971447
[TBL] [Abstract][Full Text] [Related]
7. [Gene diagnosis and CAG repeat analysis of spinocerebellar ataxia cases of Guangxi region].
Tan JQ; Wang P; Hu QP; Li SF; Shu W; Ma J; Fang L; Hua R; Ding Y; Yuan ZG
Yi Chuan; 2009 Jun; 31(6):605-10. PubMed ID: 19586860
[TBL] [Abstract][Full Text] [Related]
8. SCA2 trinucleotide expansion in German SCA patients.
Riess O; Laccone FA; Gispert S; Schöls L; Zühlke C; Vieira-Saecker AM; Herlt S; Wessel K; Epplen JT; Weber BH; Kreuz F; Chahrokh-Zadeh S; Meindl A; Lunkes A; Aguiar J; Macek M; Krebsová A; Macek M; Bürk K; Tinschert S; Schreyer I; Pulst SM; Auburger G
Neurogenetics; 1997 May; 1(1):59-64. PubMed ID: 10735276
[TBL] [Abstract][Full Text] [Related]
9. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias.
Goizet C; Lesca G; Dürr A;
Neurology; 2002 Nov; 59(9):1330-6. PubMed ID: 12427879
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial effects of predictive testing for Huntington's disease.
Hayden MR; Bombard Y
Adv Neurol; 2005; 96():226-39. PubMed ID: 16383222
[No Abstract] [Full Text] [Related]
11. ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.
Cozaru GC; Aşchie M; Mitroi AF; Poinăreanu I; Gorduza EV
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):15-22. PubMed ID: 27125067
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
13. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.
Bettencourt C; Hensman-Moss D; Flower M; Wiethoff S; Brice A; Goizet C; Stevanin G; Koutsis G; Karadima G; Panas M; Yescas-Gómez P; García-Velázquez LE; Alonso-Vilatela ME; Lima M; Raposo M; Traynor B; Sweeney M; Wood N; Giunti P; ; Durr A; Holmans P; Houlden H; Tabrizi SJ; Jones L
Ann Neurol; 2016 Jun; 79(6):983-90. PubMed ID: 27044000
[TBL] [Abstract][Full Text] [Related]
14. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease.
Robins Wahlin TB
Patient Educ Couns; 2007 Mar; 65(3):279-87. PubMed ID: 17000074
[TBL] [Abstract][Full Text] [Related]
15. Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington's disease and without mutation in the IT15 gene.
Sułek-Piatkowska A; Krysa W; Zdzienicka E; Szirkowiec W; Hoffman-Zacharska D; Rajkiewicz M; Fidziańska E; Kowalska G; Zaremba J
Neurol Neurochir Pol; 2008; 42(3):203-9. PubMed ID: 18651325
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics, Radiological Features and Gene Mutation in 10 Chinese Families with Spinocerebellar Ataxias.
Chen JW; Zhao L; Zhang F; Li L; Gu YH; Zhou JY; Zhang H; Meng M; Zhang KH; Le WD; Dong CB
Chin Med J (Engl); 2015 Jul; 128(13):1714-23. PubMed ID: 26112709
[TBL] [Abstract][Full Text] [Related]
17. Issues related to DNA testing for Huntington's disease in symptomatic patients.
Paulson GW; Prior TW
Semin Neurol; 1997; 17(3):235-8. PubMed ID: 9311065
[TBL] [Abstract][Full Text] [Related]
18. Predictive testing for Huntington's disease: ten years' experience in two Italian centres.
Mandich P; Jacopini G; Di Maria E; Sabbadini G; Abbruzzese G; Chimirri F; Bellone E; Novelletto A; Ajmar F; Frontali M
Ital J Neurol Sci; 1998 Apr; 19(2):68-74. PubMed ID: 10935839
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screening.
Bauer PO; Kotliarova SE; Matoska V; Musova Z; Hedvicakova P; Boday A; Tomek A; Nukina N; Goetz P
Genetika; 2005 Jun; 41(6):830-7. PubMed ID: 16080609
[TBL] [Abstract][Full Text] [Related]
20. Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6.
Soong B W; Lu Y C; Choo K B; Lee H Y
Arch Neurol; 2001 Jul; 58(7):1105-9. PubMed ID: 11448300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
